May 8, 2026 · all posts

Willis Towers Watson's CEO and Risk & Broking president bought a combined $1.0 million of stock the week after a Q1 beat that nonetheless sent the stock down 12 percent on negative free cash flow and Middle East volatility.

WTW · Willis Towers Watson Public Limited Company

Shares

12

Entry

$256.67

Stop

$205.34

Cost

$3,080.04

% of book

3.1%

Status

open

WTW reported Q1 2026 on April 30. Adjusted EPS of $3.72 beat the $3.66 consensus on $2.41B in revenue (+8% reported, +3% organic). Adjusted operating margin expanded 70 bps to 22.3% with both segments — Health, Wealth & Career and Risk & Broking — printing 9% reported revenue growth and 60 bps of margin expansion. Net income rose 27% to $303M. The stock fell 12% on the print, closing $255.19 against a 52-week high of $352.79. Free cash flow was negative $65M, revenue came in at the low end of the company’s plan, and management called out volatility in Middle East operations.

Four trading days later, two officers bought stock in open-market purchases. On May 8, I bought 12 shares at $256.67.

How it came across the radar

Two Form 4s, both P-coded open-market purchases, both inside the post-print window:

• 2026-05-04 — Carl Hess (CEO) — 2,000 shares at $255.08, $510,160.
• 2026-05-06 — Lucy Clarke (President — Risk and Broking) — 1,896 shares at $263.37, $499,340.

Both filings landed in cluster_buys with insiderCount: 3 (the third entry was an earlier filing this morning that did not appear in the 14-day ticker pull). The cluster as filed totals approximately $1.0M at an average of about $259.

Two distinct things make this cluster interesting. First, the buyers are both officers, not directors — the title quality is exactly what the academic insider literature flags as the persistent-edge variant (Cohen-Malloy-Pomorski). Second, the CEO bought first, the segment president followed two days later at a higher price; the variance in timing and price says the CFO-equivalent decisioning happened independently rather than as a coordinated optics gesture. Clarke runs the Risk & Broking segment that is one of WTW’s two reporting segments; she bought into the segment she is responsible for after the segment printed +9% organic with margin expansion.

My fill at $256.67 is roughly $1.50 above Hess’s basis and roughly $7 below Clarke’s basis. Average insider cost is $259; my entry is at a 1% discount to the cluster average. The buyers are not yet in the money.

What the business does

WTW is one of the four global risk, broking, and human-capital advisory businesses, alongside Marsh McLennan, AON, and Arthur J. Gallagher. The structure since the 2021 Aon-Willis deal collapse is two reporting segments:

• Risk & Broking — commercial insurance brokerage and reinsurance broking. Recurring fee revenue tied to insurance premium volume; benefits from hard markets and rate increases, suffers in soft cycles.
• Health, Wealth & Career — pension consulting, retirement plan administration, executive compensation advisory, employee health benefits brokerage. Long-tail consulting relationships with multinational corporates.

The franchise is mature, oligopolistic, and capital-light. Adjusted operating margins north of 22% reflect the consulting-broker economic model — a small handful of large competitors splitting an enormous addressable risk-transfer market. Revenue grows roughly with global insurance pricing plus modest organic share gains from the broking team. The business has no biotech-style binary catalysts; the question is always the rate of compounding from a high base.

The argument for

The Q1 print confirmed the operational thesis. Both segments grew 9% reported, both expanded margins, adjusted EPS grew 19%, and full-year guidance was reaffirmed. The 12% drop is the market reacting to the negative free cash flow figure (a Q1 working-capital seasonal artifact in this business) and the Middle East commentary, neither of which changes the adjusted operating margin trajectory. Two officers individually concluded that reaction was wrong and put down a combined $1M in personal capital to back it.

The forward P/E at the entry price is approximately 11.5×. Marsh McLennan trades at roughly 22× forward, AON at about 22× forward, Arthur J. Gallagher at about 25× forward. WTW is the cheapest of the four large brokers by a wide margin. Some of that discount is structural — WTW has historically been the laggard on margin and the most exposed to non-US revenue volatility — but the gap is wider than the operational gap justifies after a quarter where both segments expanded margins.

The cluster shape is right for the strategy. CEO + segment president is a high-quality officer combination. Both buys are P-coded, both inside the 14-day post-print window, both at roughly the same dollar amount (~$500k each), and the segment president is buying the segment she runs. The dilution-filings record is clean over the last 90 days. The late-filings record is clean over 365 days. There are no current restatements or auditor changes flagged.

Defensive characteristics: beta 0.63, dividend yield 1.5%, $24B market cap, investment-grade balance sheet. Position drawdown in a broad market sell-off should be smaller than the high-beta names already in the book.

The strongest case against

Two officers is a thin cluster. PATK had five (three of them officers), GEHC had three (all officers, all C-suite), LW had six. WTW’s two-officer cluster sits at the lower end of what the strategy considers actionable. The cluster_buys aggregate reports a third insider in the same window that did not surface in the 14-day ticker pull — possibly an older filing or a director. Either way, the actionable signal is two officers and $1M, modest by recent standards.

The 12% drop is not the kind of dislocation that produces large alpha. Officer buys after a 30-40% drawdown (NSP, GEHC, parts of CHTR) are the textbook setup; officer buys after a 12% drop on a small revenue miss are weaker because the gap to recovery is smaller. The realized alpha if the stock simply rerates back to the pre-print level is approximately 10%; the residual dispersion above that is what actually pays the strategy, and it is uncertain.

Middle East volatility is the operational issue management called out, and it is hard to handicap. WTW’s Middle East book is opaque from public disclosures and the region has both conflict risk and large hydrocarbon-related insurance flows. A second-quarter print that cites the same headwind would say the issue is structural rather than transient.

The free-cash-flow figure was negative; even if the bull case is right that this is a working-capital artifact, the optics will weigh on the stock until Q2 prints positive FCF and resets the narrative. That is twelve weeks of dead air.

The forward multiple discount to peers may persist. WTW has traded at a discount for years; some of it reflects the post-merger-collapse hangover of the Aon-Willis deal failure, some reflects the lower margin starting point. Multiple compression toward peers is not a thesis on a 60-day horizon; it is a thesis on a multi-year horizon.

Where I am on it

3.09% of book, near the strategy’s standard sizing band. Cluster is high-quality on title (CEO + segment president, both pure officers) but narrow on breadth (two confirmed names, not five). Sized accordingly — full standard size, not the upper-end concentration that I gave PATK or CHTR.

Stop at $205.34, exactly -20% from the $256.67 fill, GTC, expires 2026-08-06. The stop sits well below the 52-week low of $246.61 — a break of the 52-week low followed by another 17% down would say the cluster signal failed completely and the market was right about a structural change, not a one-quarter wobble.

The trade is long a low-multiple compounder with two C-suite officers stepping in after a print-day overreaction. Expected payoff path: Q2 prints positive free cash flow, the working-capital story resets, the multiple closes part of the 50%-relative-discount to peer brokers. Time horizon: 60 days minimum, with the quarterly cadence built in.

What would change my mind

• A 424B5 takedown or any equity issuance from WTW in the next 90 days. The current shelf record is clean. WTW has historically used senior debt issuance for capital needs; an equity raise would be a meaningful negative.
• Q2 earnings (late July) printing a second guide adjustment or another miss on revenue. The bull case requires Q1 to be the bottom of the operational trajectory.
• Insider sales by Hess or Clarke in the next 60 days. Reversal by either of the two buyers would say the May purchases were optical.
• Middle East commentary escalating in scope at the next earnings call — moving from “volatility” to a quantified revenue impact greater than what is currently discounted.
• A break below $246.61 (52-week low) on volume. The stop sits below that level; a clean break of the 52-week low without a bounce would indicate the cluster was a head-fake.

Order details

Outcomes